Aclaris Therapeutics, Inc. (0H8T.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 366.47M |
| Enterprise Value | 350.19M |
| P/E Ratio | -7.6 |
| PEG Ratio | -0.17 |
| Price/Sales Ratio | 74.94 |
| Price/Book Ratio | 5.05 |
| Enterprise/Revenue | 72.61 |
| Enterprise/EBITDA | -7.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -9.21 |
| Operating Margin | -10.5 |
AD
Management Effectiveness
| Return On Assets | -0.42 |
| Return On Equity | -0.62 |
Income Statement
| Revenue | 7.83M |
| Revenue/Share | 0.06 |
| Gross Profit | 542,000 |
| EBITDA | -73.42M |
| Net Income | -64.92M |
| Diluted EPS | -0.53 |
Balance Sheet
| Total Cash | 91.56M |
| Total Cash/Share | 0.64 |
| Total Debt | 1.85M |
| Total Debt/Equity | 0 |
| Current Ratio | 3.46 |
| Book Value Per Share | 0.87 |
Price History
| 52-Week Change | 151.64 |
| 52-Week High | 10.87 |
| 52-Week Low | 0.61 |
| Moving Average 50 Days | 1.2 |
| Moving Average 200 Days | 4.31 |
Statistics
| Average Volume | 12,279 |
| Shares Outstanding | 124.88M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
